VJHemOnc is committed to improving our service to you

SOHO 2020 | Discussing MRD testing with patients

VJHemOnc is committed to improving our service to you

William Wierda

William Wierda, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of commercialized minimal residual disease (MRD) measurements and what this means for patients specifcally. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter